Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FLAIR*: A Combined MR Contrast Technique for Visualizing White Matter Lesions and Parenchymal Veins.
Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Nicotine might have a protective effect in the etiology of multiple sclerosis.
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
Relapsing multiple sclerosis patients can look to second oral agent.
Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
Porphyrin derivatives as potent and selective blockers of neuronal Kv1 channels.
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS).
Activities of the European multiple sclerosis platform.
The risk of cancer from azathioprine as a treatment for multiple sclerosis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue.
Important role of mast cells in multiple sclerosis.
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation.
Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis.
Etiologic exploration of magnetic resonance tomographic angiography negative trigeminal neuralgia.
Promoting return of function in multiple sclerosis: An integrated approach.
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider.
Ascl1/Mash1 Promotes Brain Oligodendrogenesis during Myelination and Remyelination.
Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Pages